netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.04.01.01  Expand sub section  Oestrogens and HRT
 note 

MHRA:Further information on the known increased risk of breast cancer with HRT and its persistence after stopping

06.04.01.01  Expand sub section  Sequential combined (for women with uterus)
06.04.01.01  Expand sub section  Continuous combined (for women with uterus)
Femoston (estradiol 1 mg+ dydrogesterone 10 mg)
View adult BNF View SPC online View childrens BNF
Formulary
Blue
 
   
Femoston (estradiol 2 mg+ dydrogesterone 10 mg)
View adult BNF View SPC online View childrens BNF
Formulary
Blue
 
   
Kliofem (estradiol 2mg + norethisterone acetate 1mg)
View adult BNF View SPC online View childrens BNF
Formulary
Blue
 
   
Kliovance (estradiol 1mg + norethisterone acetate 500mcg)
View adult BNF View SPC online View childrens BNF
Formulary
Blue
 
   
Evorel Conti (estradiol ~50mcg/24hrs + norethisterone acetate ~170mcg/24hrs)
View adult BNF View SPC online View childrens BNF
Formulary
Blue

Reserved for patients unable to swallow

 
   
Femseven Conti (estradiol ~50mcg/24hrs + levonorgestrel ~7mcg/24hrs)
View adult BNF View SPC online View childrens BNF
Formulary
Blue

Reserved for patients unable to swallow

 
   
06.04.01.01  Expand sub section  Unopposed oestrogen (for women without uterus)
06.04.01.01  Expand sub section  Topical oestrogens to top
06.04.01.01  Expand sub section  Other
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Blue

For routine prescribing in primary and secondary care.   

Green

Initiated (if clinically urgent) or advised (if non-urgent) by specialist in secondary care, prescribing can be continued in primary care.   

Amber

Shared care  

Red Hospital

Hospital only  

Double Red

There should be no prescribing of these drugs  

Mixed

The traffic light of the drug is dependant on the indication. Please see individual drug entry for details  

netFormulary